Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-02

Clinical Trial Update: Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating enoxaparin for prevention of placental insufficiency in pregnant women has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Les Laboratoires des Médicaments Stériles | Conditions: Placental Insufficiency, Enoxaparin | Phase 4 | Status: COMPLETED